Safety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorOZA, A. M.
dc.contributor.authorSELLE, F.
dc.contributor.authorDAVIDENKO, I.
dc.contributor.authorKORACH, J.
dc.contributor.authorMENDIOLA, C.
dc.contributor.authorGOCZE, P.
dc.contributor.authorPAUTIER, P.
dc.contributor.authorCHMIELOWSKA, E.
dc.contributor.authorBAMIAS, A.
dc.contributor.authorDECENSI, A.
dc.contributor.authorZVIRBULE, Z.
dc.contributor.authorGONZALEZ-MARTIN, A.
dc.contributor.authorHEGG, R.
dc.contributor.authorJOLY, F.
dc.contributor.authorZAMAGNI, C.
dc.contributor.authorGADDUCCI, A.
dc.contributor.authorDEURLOO, R.
dc.contributor.authorREVIL, C.
dc.contributor.authorROBB, S.
dc.contributor.authorCOLOMBO, N.
dc.date.accessioned2016-03-24T15:00:28Z
dc.date.available2016-03-24T15:00:28Z
dc.date.issued2015
dc.description.conferencedate2015
dc.description.conferencelocalVienna, AUSTRIA
dc.description.conferencenameEuropean Cancer Congress
dc.description.indexMEDLINE
dc.identifier.citationEUROPEAN JOURNAL OF CANCER, v.51, suppl.3, p.S532-S532, 2015
dc.identifier.eissn1879-0852
dc.identifier.issn0959-8049
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/13752
dc.language.isoeng
dc.publisherELSEVIER SCI LTD
dc.relation.ispartofEuropean Journal of Cancer
dc.rightsrestrictedAccess
dc.rights.holderCopyright ELSEVIER SCI LTD
dc.subject.wosOncology
dc.titleSafety and efficacy in ROSiA, a single-arm study of extended duration front-line (FL) bevacizumab (BEV)-containing therapy in 1021 women with ovarian cancer (OC)
dc.typeconferenceObject
dc.type.categorymeeting abstract
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countryRússia
hcfmusp.affiliation.countrySuíça
hcfmusp.affiliation.countryLetônia
hcfmusp.affiliation.countryItália
hcfmusp.affiliation.countryGrécia
hcfmusp.affiliation.countryPolônia
hcfmusp.affiliation.countryHungria
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryIsrael
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryCanadá
hcfmusp.affiliation.countryisoit
hcfmusp.affiliation.countryisoca
hcfmusp.affiliation.countryisofr
hcfmusp.affiliation.countryisoru
hcfmusp.affiliation.countryisoil
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisohu
hcfmusp.affiliation.countryisopl
hcfmusp.affiliation.countryisogr
hcfmusp.affiliation.countryisolv
hcfmusp.affiliation.countryisoch
hcfmusp.author.externalOZA, A. M.:Univ Toronto, Princess Margaret Hosp, Med Oncol & Hematol, Toronto, ON, Canada
hcfmusp.author.externalSELLE, F.:Tenon Hosp, AP HP, Paris, France; Alliance Rech Cancerol, Med Oncol, Paris, France
hcfmusp.author.externalDAVIDENKO, I.:Krasnodar Region Minist Healthcare, Dept Chemotherapy, State Budgetary Healthcare Inst, Clin Oncol Dispensary 1, Krasnodar, Russia
hcfmusp.author.externalKORACH, J.:Chaim Sheba Med Ctr, Dept Gynecol Oncol, IL-52621 Tel Hashomer, Israel
hcfmusp.author.externalMENDIOLA, C.:Univ Hosp 12 Octubre, Med Oncol, Madrid, Spain
hcfmusp.author.externalGOCZE, P.:Univ Pecs, Dept Obstet & Gynecol, Fac Med, Pecs, Hungary
hcfmusp.author.externalPAUTIER, P.:Inst Gustave Roussy, Dept Med, Villejuif, France
hcfmusp.author.externalCHMIELOWSKA, E.:Oncol Ctr Prof F Lukaszczyka, Dept Clin Oncol, Bydgoszcz, Poland
hcfmusp.author.externalBAMIAS, A.:Alexandra Peripheral Gen Hosp, Dept Clin Therapeut, Athens, Greece
hcfmusp.author.externalDECENSI, A.:EO Osped Galliera, Med Oncol, Genoa, Italy
hcfmusp.author.externalZVIRBULE, Z.:Riga East Univ Hosp, Latvian Oncol Ctr, Med Oncol, Riga, Latvia
hcfmusp.author.externalGONZALEZ-MARTIN, A.:MD Anderson Canc Ctr Spain, Dept Med Oncol, Madrid, Spain
hcfmusp.author.externalJOLY, F.:Ctr Francois Baclesse, Dept Med Oncol, F-14021 Caen, France
hcfmusp.author.externalZAMAGNI, C.:St Orsola Marcello Malpighi Hosp, Med Oncol, Bologna, Italy
hcfmusp.author.externalGADDUCCI, A.:Univ Pisa, Div Obstet & Gynecol, Dept Expt & Clin Med, Pisa, Italy
hcfmusp.author.externalDEURLOO, R.:F Hoffmann La Roche Ltd, Oncol Biomarker Dev, Basel, Switzerland
hcfmusp.author.externalREVIL, C.:F Hoffmann La Roche Ltd, Stamford Consultants AG, Global Med Affairs Biometr, Basel, Switzerland
hcfmusp.author.externalROBB, S.:F Hoffmann La Roche & Co Ltd, Global Med Affairs, CH-4002 Basel, Switzerland
hcfmusp.author.externalCOLOMBO, N.:European Inst Oncol, Milan, Italy; Univ Milano Bicocca, Div Med Gynecol Oncol, Milan, Italy
hcfmusp.contributor.author-fmusphcROBERTO HEGG
hcfmusp.description.beginpageS532
hcfmusp.description.endpageS532
hcfmusp.description.issuesuppl 3
hcfmusp.description.volume51
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000361887402356
hcfmusp.publisher.cityOXFORD
hcfmusp.publisher.countryENGLAND
relation.isAuthorOfPublication137bc9f4-67c1-49b4-b313-66cbbeae2781
relation.isAuthorOfPublication.latestForDiscovery137bc9f4-67c1-49b4-b313-66cbbeae2781
Arquivos